Igc Pharma, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
AMEX
IGC Pharma, Inc. announces its 2025 Annual Meeting to vote on director elections, auditor ratification, a 5 million share incentive plan, and a significant increase in authorized common stock.
AMEX
IGC Pharma, Inc. announces its 2025 Annual Stockholders Meeting to vote on director elections, auditor ratification, a 5 million share incentive plan, and a significant increase in authorized common stock.
AMEX
DEFA14A: IGC Pharma, Inc. Sets Date for 2024 Annual Meeting, Outlines Proposals for Shareholder Vote
IGC Pharma, Inc. announces its 2024 Annual Meeting to be held on August 23, 2024, with shareholders voting on director elections, auditor ratification, and stock grant approval.
AMEX
IGC Pharma's proxy statement outlines key proposals for the upcoming annual meeting, including the election of directors, ratification of auditors, and approval of a share grant plan.